A recent study reveals low rates of upper tract urothelial carcinoma in non-muscle-invasive bladder cancer, prompting a ...

Patients with high-risk bladder cancer reported similar quality of life when treated with sasanlimab plus BCG versus BCG alone, new study data showed.

This "promising first step" could help to treat bladder, oral, head and neck tumors more effectively, said biomedical ...

Treatment with Zusduri had a median duration of response of 3.5 years and event-free survival of two years in low-grade ...

The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.

Discover a study revealing how chemotherapy-induced tumour pyroptosis reprograms fibroblasts, promoting chemoresistance in ...

The FDA has granted Priority Review to TAR-200 for the treatment of patients with BCG-unresponsive high-risk non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors ...

While we all experience minor changes in bathroom habits now and then, and it is considered normal. But sometimes, these ...

MARIETTA, Ohio (WTAP) - A benefit was held at the Reno Raceway for a local man battling bladder cancer. Mark McElfresh was ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...

Western researchers recently attracted $15M in CIHR project grants, created “to support the bold ideas and innovative work of Canada’s health researchers.” ...